Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b)

Leukemia

Volumn 10, Issue 12, 1996, Pages 1966-1970

  Zomas, A P ^a   Matutes, E ^a   Morilla, R ^a   Owusu Ankomah, K ^a   Seon, B K ^b   Catovsky, D ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

B cell leukaemias; B cell receptor; CD79b (SN8); CLL

Indexed keywords

B LYMPHOCYTE ANTIGEN; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FOLLICULAR LYMPHOMA; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MANTLE CELL LYMPHOMA; MORPHOLOGY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROTEIN EXPRESSION;

EID: 0030479831     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Catovsky D. The classification of leukemias and leukemia/lymphoma syndromes of mature B and T cells. Br J Haematol 1992; 82: 226-229.
2. Jaffe ES. The role of immunophenotypic markers in the classification of non-Hodgkin's lymphomas. Semin Oncol 1990; 17: 11-19.
3. Catovsky D, Foa R. The Lymphoid Leukemias. Butterworth: London, 1990.
4. Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1-31.
5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 1989; 42: 567-584.
6. Matutes E, Owusu-Ankomah K, Morilla R, Garcia-Marco J, Houlihan A. Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 10: 1640-1645.
7. Picker LJ, Wess LM, Medeiros LJ, Wood GS, Warnke RA. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 1987; 128: 181-201.
8. Mulligan S, Travade P, Matutes E, Dearden C, Visser L, Poppema S, Catovsky D. B-LY-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. Blood 1990; 76: 959-964.
9. Visser L, Shaw A, Slupsky J, Voss H, Poppema S. Monoclonal antibodies reactive with hairy cell leukemia. Blood 1989; 74: 320-325.
10. Okazaki M, Luo Y, Han T, Yoshida M, Seon BK. Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalised after binding to the cell surface antigen. Blood 1993; 81: 84-94.
11. Seon B, Kawata A, Yoshida M, Vasile S, Coligan JE, Tsai H, Okazaki M. Monoclonal antibody SN8 defines a unique extracellular epitope of the human B29/mb-1 heterodimer of the human B cell antigen receptor complex. Tissue Antigens 1993; 42: 315 (Abstr.).
12. Vasile S, Coligan JE, Yoshida M, Seon BK. Isolation and chemical characterisation of the human B29 and mb-1 proteins of the B-cell antigen receptor complex. Mol Immunol 1994; 31: 419-427.
13. Reth M. Antigen receptors on B lymphocytes. Annu Rev Immunol 1992; 10: 97-121.
14. Clark MR, Campbell KS, Kazlauskas A, Johnson SA, Hertz M, Potter TA, Pleiman C, Cambier JC. The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. Science 1992; 258: 123-126.
15. Pleiman CM, DiAmbrosio D, Cambier SC. The B-cell antigen receptor complex: structure and signal transduction. Immunol Today 1994; 15: 393-398.
16. Lankester AC, van-Schijndel GM, Fromme J, van-Lier RA, vanNoesel CJM. Evidence for direct physical interaction of membrane IgM, IgD, and IgG with the B29 gene product. J Immunol 1994; 152: 2157-2162.
17. Yu L, Chang TW. Human mb-1 gene: complete cDNA sequence and its expression in B cells bearing membrane Ig of various isotypes. J Immunol 1992; 148: 633-637.
18. Ha H, Kubagawa H, Burrows PD. Molecular cloning and expression pattern of a human gene homologous to the murine mb-1 gene. J Immunol 1992; 148: 1526-1531.
19. Muller B, Cooper L, Terhorst C. Cloning and sequencing of the cDNA encoding the human homologue of the murine-associated protein B29. Eur J Immmunol 22: 1621-1625.
20. Hashimoto S, Gregersen PK, Chiorazzi N. The human Ig-beta cDNA sequence, a homologue of murine B29, is identical in B-cell and plasma cell lines producing all the human Ig isotypes. J Immunol 1993; 150: 491-498.
21. Mason DY, Van Noesel CJM, Cordell JL, Comans-Bitter WM, Micklem K, Tse AG, van Lier RA, van Dongen JJ. The B29 and mb-1 polypeptides are differentially expressed during human B cell differentiation. Eur J Immunol 1992; 22: 2753-2756.
22. Buccheri V, Mihaljevic B, Matutes E, Dyer MJS, Mason DY, Catovsky D. mb-1 : a new marker for B-lineage lymphoblastic leukemia. Blood 1993; 82: 853-857.
23. Verschuren MC, Comans-Bitter WM, Kapteijn CA, Mason DY, Brouns GS, Borst J, Drexler HG, van Dongen JJ. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. Leukemia 1993; 7: 1939-1947.
24. Korkolopoulou P, Cordell J, Jones M, Kaklamanis L, Tsenga A, Gatter KC, Mason DY. The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease. Histopathology 1994; 24: 511-515.
25. Seon BK, Kawata A, Yoshida M, Vasile S, Coligan JE, Okazaki M. Monoclonal antibody SN8 defines a unique extracellular epitope of the B29/mb-1 heterodimer of the human B cell antigen receptor complex. In: Schlossman SF, Boumsell L, Gilks W et al (eds). Leukocyte Typing V. Oxford University Press: Oxford, 1995, pp 674-675.
26. Zomas A, Morilla R, Owusu-Ankomah K, Matutes E, Seon B, Catovsky D. SN8: a novel antibody for the characterisation of B-lymphoproliferative disorders. Br J Haematol 1994; 87 (Suppl. 1): 178.
27. Erber WN, Mynheer LC, Mason DY. APAAP labelling of blood and bone marrow samples for phenotyping. Lancet 1986; i: 761-765.
28. Engel P, Tedder TF. New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens. Leuk Lymphoma 1994; 13 (Suppl. 1): 61-64.
29. Tedder TF, Wagner N, Engel P. B-cell antigens report. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF, Todd RF (eds). Leukocyte Typing V. Oxford University Press: Oxford, 1995, pp 483-504.
30. van Kooten C, Rousset F, Seon BK, Blanchard D, Blancherau J. Induction of B-cell proliferation by Worshop mAb presented by CDw32-transfected L cells. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF, Todd RF (eds). Leukocyte Typing V. Oxford University Press: Oxford, 1995, pp 680-681.
31. Seon BK, Filadora VA, van Kouwenberg DA, Rybak RJ, Tsai H, Matsuno F. Suppression of human malignant B cells by a monoclonal antibody defining an extracellular epitope of Igβ of the antigen receptor complex on B cells. Proc 9th International Congress of Immunology, 23-29 July, 1995 San Francisco, CA, p 216.
32. Astsaturov IA, Matutes E, Morilla R, Seon BK, Mason DY, Farahat N, Catovsky D. Differential expression of B29 (CD79b) and mb1 (CD79a) proteins in acute lymphoblastic leukaemia. Leukemia 1996; 10: 769-773.
33. Melo JV, Catovsky D, Gregory WM, Galton DAG. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features. Br J Haematol 1987; 65: 23-29.
34. Vallespi T, Monserrat E, Sanz MA. Chronic lymphocytic leukemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients. Br J Haematol 1991; 77: 478-485.
35. Que TH, Garcia Marco J, Ellis J, Matutes E, Brito Babapulle V, Catovsky D. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype and morphology. Blood 1993; 82: 571-575.
36. Matutes E, Oscier D, Garcia Marco J, Ellis J, Copplestone A, Gillingham R, Hamblin T, Lens D, Swansbury GJ, Catovsky D. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996; 92: 382-388.
37. Galton DAG, Goldman JM, Wiltshaw E, Catovsky D, Kenry H, Goldenberg GJ. Prolymphocytic leukemia. Br J Haematol 1974; 27: 7-23.